Mettler Toledo (MTD) fundamentals: P/E, valuation, undervalued?
Mettler Toledo · Health Care · ref. ETF XLV · price $1598.03
In short — Mettler Toledo trades at 35.2× earnings (P/E), 30.9× forward, with a net margin of 21.9 % and revenue growth of +5 %. Read: Fairly valued (P/E 31 in line with ~18% growth (PEG 1.7)).
Is Mettler Toledo stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$1598.03+22.6% over range
Oct 14, 25low $1025.53 · high $1598.03Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
45% recommend buying · 11 analysts
Valuation : Fairly valued — P/E 31 in line with ~18% growth (PEG 1.7)
Valuation
35.2
P/E (price/earnings)
30.9
Forward P/E
1.93
PEG
2496.9
Price/book (P/B)
$32.0B
Market cap
45.36
EPS
Profitability & growth
21.9 %
Net margin
+5 %
Revenue growth
+18 %
Earnings growth
$2.1B
Total debt
Mettler Toledo income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $3.9B | $873M | 22.3 % |
| 2023 | $3.8B | $789M | 20.8 % |
| 2024 | $3.9B | $863M | 22.3 % |
| 2025 | $4.0B | $869M | 21.6 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Mettler Toledo's P/E and is the stock undervalued? What's a good P/E?
Mettler Toledo's P/E is 35.2 (forward 30.9). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Fairly valued".
Is Mettler Toledo profitable?
Mettler Toledo has a net margin of 21.9 % (EPS 45.36). The company is profitable.
Is MTD stock expensive?
Our read: "Fairly valued" — P/E 31 in line with ~18% growth (PEG 1.7). Cross-check with growth and sector.
💬 A question about Mettler Toledo? The JPI assistant answers using our backtest data.
Keep exploring Mettler Toledo